D.E. Shaw & Co
BEAT

D.E. Shaw & Co’s BioTelemetry, Inc. BEAT Stock Holding History

D.E. Shaw & Co’s Portfolio BEAT Stock Details BEAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-20,000
Closed -$660K – 3906
2017
Q3 		$660K Hold
20,000
– – ﹤0.01% 2754
2017
Q2 		$669K Buy
+20,000
New +$597K ﹤0.01% 2660

Other funds holding BEAT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return

D.E. Shaw & Co's BEAT Position: Q4 2017 in Review

D.E. Shaw & Co sold out of BioTelemetry, Inc. (BEAT) in Q4 2017, closing a stake of 14,265 shares — an estimated $471K sold.

D.E. Shaw & Co first reported a position in BEAT in Q2 2013 and held it in 18 quarters. The position peaked at $6.75M in Q2 2016. 192 funds tracked by Wall St. Rank hold BEAT as of Q4 2017.

  • D.E. Shaw & Co reported no remaining BioTelemetry, Inc. position as of Q4 2017 after selling out during the quarter.
  • D.E. Shaw & Co sold 14,265 BioTelemetry, Inc. shares in Q4 2017, an estimated $471K.
  • D.E. Shaw & Co first reported a position in BioTelemetry, Inc. in Q2 2013 and held it in 18 quarters.
  • D.E. Shaw & Co's BioTelemetry, Inc. position peaked at $6.75M in Q2 2016.
  • 192 funds tracked by Wall St. Rank held BioTelemetry, Inc. as of Q4 2017.

Based on D.E. Shaw & Co's 13F filing for Q4 2017, filed 14 Feb 2018.